Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabell Pink

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Virological Methods|April 17, 2023
β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog trainingVeronika Pilchová, Chittappen Kandiyil Prajeeth, Paula Jendrny, et al.
European Journal of Heart Failure|January 9, 2021
Circulating cardiovascular microRNAs in critically ill COVID-19 patientsAnkita Garg, Benjamin Seeliger, Anselm A Derda, et al.
European Journal of Immunology|March 30, 2026
Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury PatternLouisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, et al.
Journal of Clinical Medicine|January 21, 2022
Psychometric Validation of the German Translation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B)-Data from the German Bronchiectasis Registry PROGNOSISLaura Quellhorst, Grit Barten-Neiner, Andrés de Roux, et al.
European Radiology|March 9, 2024
Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRIAgilo Luitger Kern, Isabell Pink, Agnes Bonifacius, et al.
Infection|November 4, 2023
Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19Isabell Pink, Jan K Hennigs, Louisa Ruhl, et al.
Plos One|November 2, 2022
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, et al.
Scientific Reports|November 23, 2024
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infectionsAntonia Zeuzem, Saumya Dileep Kumar, Carlos Oltmanns, et al.
Signal Transduction and Targeted Therapy|December 11, 2021
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networksLouisa Ruhl, Isabell Pink, Jenny F Kühne, et al.
BMC Infectious Diseases|July 25, 2020
Scent dog identification of samples from COVID-19 patients - a pilot studyPaula Jendrny, Claudia Schulz, Friederike Twele, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Virological Methods|April 17, 2023
β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog trainingVeronika Pilchová, Chittappen Kandiyil Prajeeth, Paula Jendrny, et al.
European Journal of Heart Failure|January 9, 2021
Circulating cardiovascular microRNAs in critically ill COVID-19 patientsAnkita Garg, Benjamin Seeliger, Anselm A Derda, et al.
European Journal of Immunology|March 30, 2026
Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury PatternLouisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, et al.
Journal of Clinical Medicine|January 21, 2022
Psychometric Validation of the German Translation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B)-Data from the German Bronchiectasis Registry PROGNOSISLaura Quellhorst, Grit Barten-Neiner, Andrés de Roux, et al.
European Radiology|March 9, 2024
Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRIAgilo Luitger Kern, Isabell Pink, Agnes Bonifacius, et al.
Infection|November 4, 2023
Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19Isabell Pink, Jan K Hennigs, Louisa Ruhl, et al.
Plos One|November 2, 2022
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, et al.
Scientific Reports|November 23, 2024
Different dynamics of soluble inflammatory mediators after clearance of respiratory SARS-CoV-2 versus blood-borne hepatitis C virus infectionsAntonia Zeuzem, Saumya Dileep Kumar, Carlos Oltmanns, et al.
Signal Transduction and Targeted Therapy|December 11, 2021
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networksLouisa Ruhl, Isabell Pink, Jenny F Kühne, et al.
BMC Infectious Diseases|July 25, 2020
Scent dog identification of samples from COVID-19 patients - a pilot studyPaula Jendrny, Claudia Schulz, Friederike Twele, et al.
Pageof 5